India’s Bharat Biotech advises individuals with weak immunity to avoid its Covid-19 shots
Those with weaker immunity or who are on a medicine that affects their immune system and people with allergies have been advised against taking the Covaxin Covid-19 shot, said maker of the vaccine Bharat Biotech.
In a fact-sheet issued on Monday, two days after India began mass vaccination against Covid-19, the company said those with a history of allergies, fever, bleeding disorder or are on a blood thinner, pregnant or breastfeeding women and those with any other serious health-related issues must not be injected with Covaxin.
The Hyderabad-based pharma warned the recipients of Covaxin of severe allergic reaction that may include difficulty in breathing, swelling of the face and throat, fast heartbeat, rashes all over the body, dizziness and weakness.
Those receiving jabs are urged to disclose their medical conditions, medicines they are taking and allergies before taking the jab, according to the fact-sheet.
Earlier, the Indian Health Ministry had said that patients who are on immuno-suppressants or suffer from immune deficiency could take the vaccine but the response would be less effective in such individuals.
India began its mammoth vaccinating campaign on January 16 using two vaccines -- Covaxin and Oxford-AstraZeneca vaccine Covishield produced by Serum Institute of India.
Some 580 adverse reactions and two deaths -- in Uttar Pradesh and Karnataka states -- that are unrelated to the vaccine have been reported, the Health Ministry said last night.
Today, India reported the lowest number of daily coronavirus infections in over seven months with 10,064 new cases, which took the total caseload to 1,05,81,837, according to updated Health Ministry data.
The country's death toll due to the virus increased to 1,52,556 as 137 fatalities, the lowest in around eight months, were recorded in a span of 24 hours, the data showed.
Comments